Non-dysplastic Barrett's oesophagus (NDBE) occurs as a consequence of an inflammatory response triggered through prolonged gastro-oesophageal reflux and it may precede the development of oesophageal adenocarcinoma. NF-jB activation as a result of the inflammatory response has been shown in NDBE, but the possible mechanism involved in the process is unknown. The aim of this study was to assess, using immunohistochemistry, Survivin and Bcl3 expression as potential biomarkers for NF-jB activation along the oesophageal metaplasia-dysplasia-adenocarcinoma sequence. Survivin is an NF-jB-inducible anti-apoptotic protein, and Bcl3 is a negative regulator of NF-jB. There was progressive upregulation of Survivin expression along the oesophageal metaplasia-dysplasia-adenocarcinoma sequence. Bcl3 expression was upregulated in non-dysplastic Barrett's oesophagus, low-grade, high-grade dysplasia and oesophageal adenocarcinoma when compared to squamous group. The study shows the differential expression of Bcl3 between the squamous and Barrett's stage, suggesting that Bcl3 could be a surrogate marker for early event involving constitutive NF-jB activation. In addition, the study suggests that NF-jB activation may infer resistance to apoptosis through the expression of anti-apoptotic genes such as Survivin, which showed progressive increase in expression throughout the oesophageal metaplasia-dysplasia-adenocarcinoma sequence. This ability to avoid apoptosis may underlie the persistence and malignant predisposition of Barrett's metaplasia.
Introduction
Non-dysplastic Barrett's oesophagus (NDBE) is defined as the replacement of the normal squamous epithelium of the lower oesophagus by metaplastic columnar epithelium (Garud et al. 2010) . It occurs as a consequence of the inflammatory response triggered through prolonged gastrooesophageal reflux and precedes the development of oesophageal adenocarcinoma, which is a malignancy that has shown a rapidly rising incidence over the last two decades (Pohl & Welch 2005) and currently has the third worst survival rate amongst cancers in men in the United Kingdom (CRUK Oesophageal Cancer Statistics). Most cases of NDBE will not progress to oesophageal adenocarcinoma (OAC); however, its presence is an indication for further endoscopic biopsy surveillance (Pohl & Welch 2005) .
Inappropriate activation of nuclear factor kappa B (NF-jB) has been linked to a variety of inflammatory and neoplastic conditions including colorectal, breast (Buckley et al. 2016 ) and prostate cancers (Mak et al. 2015) . NF-jB activation occurs in oesophageal cancer cell lines in response to acid and bile, and a marked overexpression of NF-jB in patients with NDBE or OAC has been reported (Abdel-Latif et al. 2004; O'Riordan et al. 2005) . NF-jB is a ubiquitous transcription factor that regulates the activation of many NF-jB-inducible genes involved in pro-inflammatory responses, differentiation and growth (Baeuerle & Baltimore 1996; Chen et al. 1999) . NF-jB resides in the cytoplasm of most cells in an inactive form as a heterodimer consisting of p65, p50 and RelA subunits complexed to inhibitory molecules Bcl3, IjBa, IjBb, IjBc, IjBe and IjBϛ, which prevent the migration of the heterodimer to the nucleus (Yamamoto & Gaynor 2004) .
Bcl3 is a key negative feedback regulator of the NF-jB pathway and is known to be overexpressed in different tumours such as colorectal (Saamarthy et al. 2015) , breast (Cogswell et al. 2000) , nasopharyngeal (Thornburg et al. 2003) , endometrial (Pallares et al. 2004) , prostate cancer (Ahlqvist et al. 2013 ) and cervical carcinoma (Zhao et al. 2016) . In addition, Bcl3 was shown to be a prognostic biomarker for inflammatory diseases such as ulcerative colitis (Reissig et al. 2017) . Survivin is an anti-apoptotic, NF-jBinducible gene (Kawakami et al. 2005; Wang et al. 2010) . It is involved in the control of proliferation and apoptosis in T-cell development (Xing et al. 2004) in various cancers such as myeloma (Locke et al. 2015) , lung cancer (Li & Ding 2015) and ovarian cancer (Berinstein et al. 2015) .
The aim of this study is to assess Bcl3 and Survivin expression in a series of biopsies spanning the oesophageal Barrett metaplasia-dysplasia-adenocarcinoma sequence highlighting their roles in the initiation and progression to oesophageal adenocarcinoma. Bcl3 expression would suggest a possible molecular mechanism of NF-jB activation involved in the initiation of the inflammatory process. Survivin expression would suggest a possible role in the progression to oesophageal adenocarcinoma.
Materials and methods

Patients and samples
A panel of formalin fixed paraffin-embedded (FFPE) oesophageal specimens (biopsies and endoscopic mucosal resections) of normal and pathological oesophagus was identified from the University College London Hospital upper gastrointestinal clinical database. Ethical approval was obtained from the UK Research Ethics Committee (15/YH/0311; 08/ H808/8; 08/H0714/27).
Samples were selected from 74 independent patients containing, in order of disease severity; normal squamous tissue (n = 12; Sq), non-dysplastic Barrett's epithelium (n = 16; NDBE), low-grade dysplasia (n = 10; LGD), high-grade dysplasia (n = 22; HGD) and invasive oesophageal adenocarcinoma (n = 14; OAC). The samples chosen were of the highest pathological grade the patient had at the time of sampling. Sections were stained with haematoxylin and eosin (H&E) and the reported pathological grade confirmed by two expert GI pathologists (MN, MRJ). All cases in each group were homogenous for disease grade. Biopsies predominantly represented mucosal tissue, although some adenocarcinoma samples included submucosal tissue (e.g. endoscopic resection specimen).
Immunohistochemistry
Immunohistochemistry (IHC) for Survivin and Bcl3 proteins was carried out using the automated Bond-Max system (Leica Biosystems Ltd., Newcastle) using 4-lm FFPE sections. Antigen retrieval used Bond epitope retrieval solution 2 (EDTA based on pH 9.0) for 20 min prior to incubation with either Survivin [clone D-8 sc-17779 (Santa Cruz Biotechnology)] and Bcl3 (clone 1E8 Leica Biosystems Ltd) (1:150). Slides were counterstained with haematoxylin and mounted using DPX. IHC for Bcl3 demonstrated nuclear and cytoplasmic localization whilst Survivin demonstrated nuclear localization on examination of tonsil and diffuse large B-cell lymphoma sections as positive control.
Interpretation
Prior to inclusion in this study, all H&E-stained sections were reviewed by gastrointestinal histopathologists (MRJ and MN) to confirm the classification. All slides were scored by MN, MRJ using the Allred scoring system (Allred et al. 1998) to take into account heterogeneous staining. The Allred system scores IHC intensity positivity as negative (0), weak (1), moderate (2) and strong (3+). Separately scores the extent of biomarker positivity according to the proportion of tissues positively stained as negative (0), <1% (1), 1-10% (2), 11-33% (3), 34-66% (4) and 67-100% (5), and the final Allred score is the addition of these two scores. For Bcl3 staining, the nuclear and cytoplasmic intensity staining was added to give a final intensity score. Positive cases were defined as those staining 2+/3+ intensity in >10% of the pathology examined.
Statistical analysis
Multivariate analysis was carried out using the KruskalWallis test across the five histological groups: squamous (Sq), non-dysplastic Barrett's oesophagus (NDBE), lowgrade dysplasia (LGD), high-grade dysplasia (HGD) and oesophageal adenocarcinoma (OAC). Two-way comparisons between the groups were carried out using the Mann-Whitney U-test. P < 0.05 was taken to be statistically significant. All statistical analysis was carried out using SPSS (IBM, UK).
Results
Clinicopathological features of the patients
Tissue samples from 74 patients were analysed to provide an overview of the oesophageal Barrett metaplasia-dysplasia-adenocarcinoma sequence. The main clinical and Bcl3 staining along the oesophageal metaplasiadysplasia-adenocarcinoma sequence Sections from patients along the oesophageal Barrett metaplasia-dysplasia-adenocarcinoma sequence were stained for Bcl3 using immunohistochemistry (Figure 1, a-e) . Bcl3 was noted in both the cytoplasm and nucleus in all samples. Staining was scored using the semiquantitative Allred method to take into account the heterogeneity (Figure 2 ). Bcl3 staining did not change along the sequence, however when compared to Sq; NDBE, LGD, HGD and OAC demonstrated Allred mean fold change of 2.68, 1.82, 2.48 and 2.79 respectively. In addition, compared to Sq, there is evidence of upregulation of Bcl3 in NDBE (P = 0.0006), HGD (P = 0.0022) and OAC (P = 0.0012).
Survivin staining along the oesophageal metaplasiadysplasia-adenocarcinoma sequence
After staining for Bcl3, sequential sections were stained with Survivin, which showed a nuclear distribution consistent (Figure 1, f-i) . Compared to Sq, all neoplastic tissues showed increased staining with Allred mean scores of NDBE 2.81 (P = 0.0264), LGD 4.50 (P = 0.0011), HGD 4.64 (P < 0.0001) and OAC 5.79 (P < 0.0001) respectively (Figure 3 ). All diagnostic categories showed a wide range of scores; however, there was clear evidence of a progressive increase in Survivin in NDBE through LGD, HGD to OAC (P < 0.0001, using the Kruskal-Wallis test).
Discussion
In this study, we have demonstrated for the first time the differential expression of Bcl3 between squamous and Barrett's mucosa and progressive increase in Survivin expression along the Barrett's metaplasia-dysplasia-adenocarcinoma sequence in the oesophagus.
The role of Bcl3 in the NF-jB pathway has previously been described (Cogswell et al. 2000) , and our results show, for what we believe is the first time, the differential expression of Bcl3 in squamous and higher grade oesophageal neoplasia samples implying that Bcl3 may be involved in the constitutive activation of the NF-jB pathway, which is an early event in the metaplasia-dysplasia-carcinoma sequence (Abdel-Latif et al. 2004) . Given that the NF-jB pathway is known to initiate the inflammatory response, we hypothesize that Bcl3 may be responsible for the inflammatory response that is known to occur in Barrett's oesophagus (Abdel-Latif et al. 2004; O'Riordan et al. 2005; Hormi-Carver et al. 2009 ). Interestingly, Bcl3 expression seems to suggest constitutive NF-jB activation, which occurs in NDBE and remains high in LGD, HGD and OAC compared to Sq. The results suggest that the cohort of normal squamous is likely to exhibit some abnormal phenotype suggesting that inflammation has already occurred probably due to acid or bile reflux. Also, the high Bcl3 expression in the latter stages of the metaplasia-carcinoma sequence compared to Sq suggests continuation in inflammatory signatures, probably due to the fact that chronic inflammation has developed at those stages.
Few studies have used immunohistochemistry of the NF-jB subunits such as p50 and p65 to show constitutive NF-jB activation; however, this has been shown to be unreliable because NF-jB subunits shuttle between the nucleus and cytoplasm in constitutively active NF-jB cells (Herkenham et al. 2011) . In this study, we show that measuring the NF-jB inhibitors such as Bcl3 may be a more reliable measure of constitutive NF-jB activation.
Survivin expression progressively increases along the Barrett's metaplasia-dysplasia-adenocarcinoma sequence indicating that it could potentially be a useful biomarker for the progression to OAC. Survivin is an anti-apoptotic gene that is a member of the IAP family (Zhao et al. 2016) . It is also NF-jB-inducible gene (Kawakami et al. 2005; Wang et al. 2010) and has been shown to be involved in proliferation and apoptosis during T-cell development (Song et al. 2008) , both of which are important in the development of oesophageal adenocarcinoma.
Taken together, Bcl3 overexpression could be a surrogate biomarker for NF-jB activation in Barrett's epithelial cells leading to deregulation of NF-jB-inducible gene expression, inferring resistance to apoptosis through the activation of anti-apoptotic genes such as Survivin. This ability to avoid apoptosis may underlie the persistence and malignant predisposition of Barrett's metaplasia.
Conclusions
This study demonstrated for the first time the differential expression of Bcl3 between normal squamous mucosa and NDBE, indicating an early mechanism of NF-jB activation that might play a role in the initiation of inflammation in response to acid or bile reflux. In addition, the study showed that NF-jB activation may infer resistance to apoptosis through the activation of anti-apoptotic NF-jB-inducible genes such as Survivin, which is known to be involved in proliferation and apoptosis during T-cell development. Survivin showed progressive upregulation through the oesophageal metaplasia-dysplasia-adenocarcinoma sequence showing its importance in the progression to OAC. This ability to avoid apoptosis may underlie the persistence and malignant predisposition of Barrett's metaplasia. Therefore, Bcl3 can be used as early biomarker for of NDBE and Survivin can be used as biomarker for the progression of NDBE to OAC. 
